GlobalDeal

Novimmune

Biotechnology · Geneva, Switzerland

novimmune.com

About Novimmune

Novimmune is a biopharmaceutical company focused on the discovery and development of innovative therapeutic antibodies for the treatment of serious diseases. Founded in 2007 and headquartered in Geneva, Switzerland, Novimmune has developed a robust pipeline of monoclonal antibodies targeting various diseases, including autoimmune disorders, cancer, and infectious diseases. The company leverages its proprietary technology platforms to create highly specific and effective treatments, aiming to improve patient outcomes and quality of life. Novimmune collaborates with leading academic institutions and industry partners to advance its research and development efforts, ensuring that its therapies are based on the latest scientific advancements. The company is committed to maintaining high standards of quality and compliance in its operations, with a focus on bringing novel therapies to market that address unmet medical needs.

Company facts

Industry
Biotechnology
Sub-industries
Pharmaceuticals, Monoclonal Antibodies, Therapeutics, Autoimmune Disorders, Oncology
Location
Geneva, Switzerland
Employees
11–50
Revenue (USD)
1–5M
Founded
2007

Products and services

Open Novimmune in GlobalDeal Is this your company? Update the details for free

More Biotechnology companies in Switzerland

All 636 Biotechnology companies in Switzerland →